Innovation to Investment

Convincing others to invest in an innovation is the single most important activity you will pursue on the commercialization path. But investors do not invest in technology alone. Investors invest in business opportunities.

At Biomedical Commercialization Canada (BCC), we can help you turn your innovation into an enterprise. Help you make a viable product or service come alive. Help your start-up technology company grow ready for major capital investment... sooner.

We know the hurdles of technology commercialization; from working model to break even analysis, we're familiar with the twists and turns the road to the market can take. We can assist you in achieving more... faster.

We're an organization with business and industry knowledge and experience that runs deep. Our network of research, industry and investment collaborators will provide feedback that will assist you in moving your innovation through the activities that are essential in attracting the investment needed for success.

Our programs and services are flexible and dynamic like the entrepreneurial world in which we work. Located at the new Centre for the Commercialization of Biomedical Technology in Winnipeg, our focus is nationwide as we effectively close the miles between us.

BCC is a unique option for technology commercialization. As a client, you're in the driver's seat. You gain knowledge from our programs/services and experience from our tailored coaching. Where others may develop plans, we help you plan and implement strategies and tactics all along the way. You can spend years establishing connections in fields ranging from capital investment to regulatory requirements or you can take advantage of our expertise and network. Where infrastructure support such as office space is available elsewhere, it's just one aspect of all that you gain as a BCC client.

Take a few minutes to learn more about us here and by talking to us. We'd be pleased to show you how to move from innovation to investment.

Marshall Ring

Executive Director
Biomedical Commercialization Canada